\
&
Contact us
\
&
Contact us
Published on | 4 years ago
Programmes ERCPrincipal Investigators with an ERC grant that is running or ended less than 12 months before 1 January of the call year are eligible to participate in an ERC Proof of Concept Grant. The results of the 2020 Proof of Concept call (3rd cut-off 17 September 2020) were published. In total 55 ERC grant holders received a Proof of Concept grant including two researchers based at Flemish host institutions:
FWO press release – Onderzoekers vertellen: Kevin Braeckmans
Related news article
ERC - Number of proposals submitted Proof of Concept 2020 call, 3rd cut-off
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
Digital, Industry & Space Digital Europe AI Continent Cybersecurity
Flanders is pursuing an active industry and export policy focused on defence innovation. With the Flemish Innovation and Industry Strategy for Security and Defence (VISD) and a new weapon trading decree, the government plans to help local companies market their technologies internationally. The European defence and security market is rapidly expan... read more
The Horizon2020 project BEAT-AF brings together 9 European renowned clinical centres in France, Belgium, Czechia, Germany and Austria. Together, the consortium strives to revolutionize Atrial Fibrillation (AF) treatment through catheter ablation and contribute to decrease the huge burden of AF in Europe. The BEAT-AF project kicked off in 2021 and will run until 2026. The department of electrophysiology of the AZ Sint-Jan Hospital in Bruges is partner in the project and has so far contributed to the pre-clinical development, the first in man studies and first registries of the revolutionary AF treatment put forward by the consortium. The first pilot studies show that the treatment is safe, effective and efficient.
